DOBUTAMINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dobutamine Hydrochloride, and what generic alternatives are available?
Dobutamine Hydrochloride is a drug marketed by Baxter Hlthcare, Dr Reddys, Hikma, Hospira, Luitpold, Slate Run Pharma, Teligent, Teva Parenteral, Watson Labs, and Watson Labs Inc. and is included in fifteen NDAs.
The generic ingredient in DOBUTAMINE HYDROCHLORIDE is dobutamine hydrochloride. There are fourteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dobutamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dobutamine Hydrochloride
A generic version of DOBUTAMINE HYDROCHLORIDE was approved as dobutamine hydrochloride by HOSPIRA on November 29th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DOBUTAMINE HYDROCHLORIDE?
- What are the global sales for DOBUTAMINE HYDROCHLORIDE?
- What is Average Wholesale Price for DOBUTAMINE HYDROCHLORIDE?
Summary for DOBUTAMINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 15 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 102 |
| Clinical Trials: | 117 |
| Patent Applications: | 740 |
| What excipients (inactive ingredients) are in DOBUTAMINE HYDROCHLORIDE? | DOBUTAMINE HYDROCHLORIDE excipients list |
| DailyMed Link: | DOBUTAMINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for DOBUTAMINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu | N/A |
| Koç University | N/A |
| Wuhan Union Hospital, China | Phase 2/Phase 3 |
Pharmacology for DOBUTAMINE HYDROCHLORIDE
| Drug Class | beta-Adrenergic Agonist |
| Mechanism of Action | Adrenergic beta-Agonists |
Medical Subject Heading (MeSH) Categories for DOBUTAMINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for DOBUTAMINE HYDROCHLORIDE
US Patents and Regulatory Information for DOBUTAMINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | DOBUTAMINE HYDROCHLORIDE | dobutamine hydrochloride | INJECTABLE;INJECTION | 074381-001 | Sep 26, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Baxter Hlthcare | DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER | dobutamine hydrochloride | INJECTABLE;INJECTION | 020255-004 | Oct 19, 1993 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Luitpold | DOBUTAMINE HYDROCHLORIDE | dobutamine hydrochloride | INJECTABLE;INJECTION | 074545-001 | Jun 25, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
